This course has expired. Voir les cours disponibles.
Infectious Disease
Updating our COVID-19 booster strategy – Answering questions about the new bivalent booster
With the introduction of the bivalent COVID-19 booster, both patients and healthcare professionals have questions regarding the efficacy, safety, and role of this new booster option in protection from COVID-19. During this webinar, experts answer the most common questions regarding the bivalent COVID-19 booster, the impact of omicron on the booster strategy and help healthcare professionals become better equipped to address common patient questions regarding COVID-19 protection with mRNA vaccines.
Durée
1 hr
Profession
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# des crédits
0
Accréditation
Unaccredited
Date d'expiration
2023-11-10
With the introduction of the bivalent COVID-19 booster, both patients and healthcare professionals have questions regarding the efficacy, safety, and role of this new booster option in protection from COVID-19. During this webinar, experts answer the most common questions regarding the bivalent COVID-19 booster, the impact of omicron on the booster strategy and help healthcare professionals become better equipped to address common patient questions regarding COVID-19 protection with mRNA vaccines.
This program has received funding from Moderna.
La Faculté
Vivien Brown, MDCM, CCFP, FCFP, NCMP (Moderator)
Peter Lin, MD, CCFP
David Strain, MBChB, MD, FRCP
Allison McGeer, MD, FRCPC
Objectifs d'apprentissage
Upon completion of this continuing education video participants will be better able to:
- Describe why the omicron variant has led to the development of a different COVID-19 vaccine strategy
- Address common patient questions on the efficacy and safety of the new COVID-19 bivalent booster
- Discuss the bivalent booster that is available and the advantages/disadvantages of this option